Stocks and Investing
Stocks and Investing
Tue, December 15, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Elemer Piros Maintained (APLS) at Strong Buy with Increased Target to $73 on, Dec 15th, 2020
Elemer Piros of Roth Capital, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $50 to $73 on, Dec 15th, 2020.
Elemer has made no other calls on APLS in the last 4 months.
There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 0 agree with Elemer's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Elemer
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $67 on, Monday, November 23rd, 2020
- Joseph Stringer of "Needham" Initiated at Strong Buy and Held Target at $59 on, Thursday, November 19th, 2020
- Derek Archila of "Stifel" Initiated at Strong Buy and Held Target at $40 on, Tuesday, September 1st, 2020
Contributing Sources